GlassScriptPhysician profile
Elsy Marquez
NPI 1740230986
$4,796.42
in general payments reported to CMS, 2019-2025
18 companies · $421 in 2025
The $421 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,543 · 2022: $779 · 2023: $380 · 2024: $672 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,474.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $1,328.26 | 2021-2022 | |
| Novo Nordisk INC | $541.59 | 2021-2025 | Ozempic |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $466.21 | 2024-2025 | Caplyta |
| Astrazeneca Pharmaceuticals LP | $382.85 | 2021-2022 | |
| Amgen INC. | $336.69 | 2021 | |
| Abbott Laboratories | $233.86 | 2022-2024 | Supera |
| Abbvie INC. | $212.18 | 2021-2023 | |
| Davol INC. | $147.28 | 2022 | |
| Glaxosmithkline, LLC. | $147.22 | 2021 | |
| Heartflow, INC. | $147.18 | 2024 | |
| Boston Scientific Corporation | $146.77 | 2021 | |
| Janssen Pharmaceuticals, INC | $129.75 | 2023 | Xarelto |
| Xeris Pharmaceuticals, INC. | $125.70 | 2023 | Gvoke Hypopen |
| Eisai INC. | $121.87 | 2024 | |
| Lilly USA, LLC | $114.40 | 2025 | Zepbound |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $113.11 | 2022 | |
| Merck Sharp & Dohme LLC | $79.75 | 2022 | |
| Becton, Dickinson and Company | $21.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elsy Marquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.